These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35245482)

  • 1. Combined metabolomics with transcriptomics reveals potential plasma biomarkers correlated with non-small-cell lung cancer proliferation through the Akt pathway.
    Zheng J; Zheng Y; Li W; Zhi J; Huang X; Zhu W; Liu Z; Gong L
    Clin Chim Acta; 2022 May; 530():66-73. PubMed ID: 35245482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarker identification and pathway analysis of rheumatoid arthritis based on metabolomics in combination with ingenuity pathway analysis.
    He Z; Liu Z; Gong L
    Proteomics; 2021 Jun; 21(11-12):e2100037. PubMed ID: 33969925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined Metabolomics with Transcriptomics Reveals Important Serum Biomarkers Correlated with Lung Cancer Proliferation through a Calcium Signaling Pathway.
    Zheng Y; He Z; Kong Y; Huang X; Zhu W; Liu Z; Gong L
    J Proteome Res; 2021 Jul; 20(7):3444-3454. PubMed ID: 34056907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum untargeted metabolomics reveal metabolic alteration of non-small cell lung cancer and refine disease detection.
    Li J; Liu K; Ji Z; Wang Y; Yin T; Long T; Shen Y; Cheng L
    Cancer Sci; 2023 Feb; 114(2):680-689. PubMed ID: 36310111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
    Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
    J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortisol, cortisone, and 4-methoxyphenylacetic acid as potential plasma biomarkers for early detection of non-small cell lung cancer.
    Xiang C; Jin S; Zhang J; Chen M; Xia Y; Shu Y; Guo R
    Int J Biol Markers; 2018 Aug; 33(3):314-320. PubMed ID: 29896992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study on plasma amino acids and piperonamide as potential diagnostic biomarkers of non-small cell lung cancer.
    Zhang C; Wang Y; Cao Y; Shi L; Wang R; Sheng N; Wang Q; Zhu Z
    Transl Cancer Res; 2022 May; 11(5):1269-1284. PubMed ID: 35706818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma metabolomics for the assessment of the progression of non-small cell lung cancer.
    Zhang Y; Cheng Y; Qin L; Liu Y; Huang S; Dai L; Tao J; Pan J; Su C; Zhang Y
    Int J Biol Markers; 2023 Mar; 38(1):37-45. PubMed ID: 36377344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot study identifying a potential plasma biomarker for determining EGFR mutations in exons 19 or 21 in lung cancer patients.
    Pamungkas AD; Medriano CA; Sim E; Lee S; Park YH
    Mol Med Rep; 2017 Jun; 15(6):4155-4161. PubMed ID: 28487968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non-small cell lung cancer.
    Xie Y; Zhang Y; Du L; Jiang X; Yan S; Duan W; Li J; Zhan Y; Wang L; Zhang S; Li S; Wang L; Xu S; Wang C
    Mol Oncol; 2018 May; 12(5):648-658. PubMed ID: 29504701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integration of metabolomics and machine learning revealed tryptophan metabolites are sensitive biomarkers of pemetrexed efficacy in non-small cell lung cancer.
    Sun R; Fei F; Wang M; Jiang J; Yang G; Yang N; Jin D; Xu Z; Cao B; Li J
    Cancer Med; 2023 Sep; 12(18):19245-19259. PubMed ID: 37605514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomics of papillary thyroid carcinoma tissues: potential biomarkers for diagnosis and promising targets for therapy.
    Shang X; Zhong X; Tian X
    Tumour Biol; 2016 Aug; 37(8):11163-75. PubMed ID: 26935059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive analysis of metabolomics and transcriptomics in non-small cell lung cancer.
    Ruiying C; Zeyun L; Yongliang Y; Zijia Z; Ji Z; Xin T; Xiaojian Z
    PLoS One; 2020; 15(5):e0232272. PubMed ID: 32374740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dramatically changed immune-related molecules as early diagnostic biomarkers of non-small cell lung cancer.
    Ye X; Zhang N; Jin Y; Xu B; Guo C; Wang X; Su Y; Yang Q; Song J; Yu W; Cheng P; Cheng L; Gong Y; Fu X; Sun H
    FEBS J; 2020 Feb; 287(4):783-799. PubMed ID: 31482685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer detection using targeted plasma metabolomics.
    Jasbi P; Wang D; Cheng SL; Fei Q; Cui JY; Liu L; Wei Y; Raftery D; Gu H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jan; 1105():26-37. PubMed ID: 30562627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using biological information to analyze potential miRNA-mRNA regulatory networks in the plasma of patients with non-small cell lung cancer.
    Zhang W; Zhang Q; Che L; Xie Z; Cai X; Gong L; Li Z; Liu D; Liu S
    BMC Cancer; 2022 Mar; 22(1):299. PubMed ID: 35313857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A circulating non-coding RNA panel as an early detection predictor of non-small cell lung cancer.
    Peng H; Wang J; Li J; Zhao M; Huang SK; Gu YY; Li Y; Sun XJ; Yang L; Luo Q; Huang CZ
    Life Sci; 2016 Apr; 151():235-242. PubMed ID: 26946307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined analysis of gut microbiome and serum metabolomics reveals novel biomarkers in patients with early-stage non-small cell lung cancer.
    Ni B; Kong X; Yan Y; Fu B; Zhou F; Xu S
    Front Cell Infect Microbiol; 2023; 13():1091825. PubMed ID: 36743312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liquid Chromatography-Mass Spectrometry-Based Tissue Metabolic Profiling Reveals Major Metabolic Pathway Alterations and Potential Biomarkers of Lung Cancer.
    You L; Fan Y; Liu X; Shao S; Guo L; Noreldeen HAA; Li Z; Ouyang Y; Li E; Pan X; Liu T; Tian X; Ye F; Li X; Xu G
    J Proteome Res; 2020 Sep; 19(9):3750-3760. PubMed ID: 32693607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possibility of multivariate function composed of plasma amino acid profiles as a novel screening index for non-small cell lung cancer: a case control study.
    Maeda J; Higashiyama M; Imaizumi A; Nakayama T; Yamamoto H; Daimon T; Yamakado M; Imamura F; Kodama K
    BMC Cancer; 2010 Dec; 10():690. PubMed ID: 21176209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.